These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38919512)

  • 1. Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIV.
    Roen AO; Peters L; Wandeler G; van der Valk M; Zangerle R; Günthard HF; Wit F; Mussini C; De Wit S; d'Arminio Monforte A; Vehreschild JJ; Castagna A; Jaschinski N; Vannappagari V; Chen L; Tallada J; C'mar J; Mocroft A; Ryom L
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae308. PubMed ID: 38919512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.
    Kovari H; Sabin CA; Ledergerber B; Ryom L; Reiss P; Law M; Pradier C; Dabis F; d'Arminio Monforte A; Smith C; de Wit S; Kirk O; Lundgren JD; Weber R
    Open Forum Infect Dis; 2016 Jan; 3(1):ofw009. PubMed ID: 26925429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era.
    Wood S; Won SH; Hsieh HC; Lalani T; Kronmann K; Maves RC; Utz G; Schofield C; Colombo RE; Okulicz JF; Blaylock J; Agan BK; Ganesan A
    Open Forum Infect Dis; 2021 Mar; 8(3):ofab076. PubMed ID: 33738323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens.
    Nkhoma ET; Rosenblatt L; Myers J; Villasis-Keever A; Coumbis J
    PLoS One; 2016; 11(12):e0166982. PubMed ID: 27941989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.
    Gianotti N; Galli L; Poli A; Salpietro S; Nozza S; Carbone A; Merli M; Ripa M; Lazzarin A; Castagna A
    Medicine (Baltimore); 2016 May; 95(22):e3780. PubMed ID: 27258510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
    Nikolaichuk M; Mocroft A; Wandeler G; Szlavik J; Gottfredsson M; Reikvam DH; Svedhem V; Elinav H; Laguno M; Mansinho K; Devitt E; Chkhartishvili N; Behrens G; Bogner J; Viard JP; Winston A; Benfield T; Leen C; Fursa O; Rockstroh J; Peters L;
    HIV Med; 2023 Feb; 24(2):224-230. PubMed ID: 35934954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
    Byonanebye DM; Polizzotto MN; Maltez F; Rauch A; Grabmeier-Pfistershammer K; Wit F; De Wit S; Castagna A; d'Arminio Monforte A; Mussini C; Wasmuth JC; Fontas E; Abela I; Sarcletti M; Bansi-Matharu L; Jaschinski N; Peters L; Hosein SR; Vannappagari V; Cohen C; Bissio E; Mocroft A; Law M; Ryom L; Petoumenos K;
    Lancet HIV; 2024 May; 11(5):e321-e332. PubMed ID: 38621392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
    Borges ÁH; Hoy J; Florence E; Sedlacek D; Stellbrink HJ; Uzdaviniene V; Tomazic J; Gargalianos-Kakolyris P; Schmid P; Orkin C; Pedersen C; Leen C; Pradier C; Mulcahy F; Ridolfo AL; Staub T; Maltez F; Weber R; Flamholc L; Kyselyova G; Lundgren JD; Mocroft A;
    Clin Infect Dis; 2017 May; 64(10):1413-1421. PubMed ID: 28329090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.
    Suzuki S; Nishijima T; Kawasaki Y; Kurosawa T; Mutoh Y; Kikuchi Y; Gatanaga H; Oka S
    AIDS Patient Care STDS; 2017 Mar; 31(3):105-112. PubMed ID: 28282247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
    Ryom L; Mocroft A; Kirk O; Worm SW; Kamara DA; Reiss P; Ross M; Fux CA; Morlat P; Moranne O; Smith C; Lundgren JD;
    J Infect Dis; 2013 May; 207(9):1359-69. PubMed ID: 23382571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.
    Ryom L; Lundgren JD; El-Sadr W; Reiss P; Kirk O; Law M; Phillips A; Weber R; Fontas E; d' Arminio Monforte A; De Wit S; Dabis F; Hatleberg CI; Sabin C; Mocroft A;
    Lancet HIV; 2018 Jun; 5(6):e291-e300. PubMed ID: 29731407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of antiretroviral therapy has low impact on weight gain.
    Drechsler H; Ayers C; Oboho I; Enwerem N; Hanna J; Clark C; Kitchell E; Jain M; Luque A; Bedimo R
    AIDS; 2024 Jun; ():. PubMed ID: 38831733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neither boosted elvitegravir nor darunavir with emtricitabine/tenofovir disoproxil fumarate increase insulin resistance in healthy volunteers: results from the STRIBILD-IR study.
    Spinner CD; Kern KE; Zink A; Wolf E; Balogh A; Noe S; Von Werder A; Schwerdtfeger C; Schmid RM; Iakoubov R
    Antivir Ther; 2016; 21(7):627-631. PubMed ID: 27050630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens.
    Varriano B; Crouzat F; Sandler I; Smith G; Kovacs C; Gupta M; Brunetta J; Fletcher D; Knox D; Merkley B; Chang B; Tilley D; Acsai M; Loutfy M
    AIDS Res Hum Retroviruses; 2021 Jan; 37(1):44-53. PubMed ID: 33019803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.
    Paredes R; Tzou PL; van Zyl G; Barrow G; Camacho R; Carmona S; Grant PM; Gupta RK; Hamers RL; Harrigan PR; Jordan MR; Kantor R; Katzenstein DA; Kuritzkes DR; Maldarelli F; Otelea D; Wallis CL; Schapiro JM; Shafer RW
    PLoS One; 2017; 12(7):e0181357. PubMed ID: 28753637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.
    Hsu R; Brunet L; Fusco J; Beyer A; Prajapati G; Wyatt C; Wohlfeiler M; Fusco G
    HIV Med; 2021 May; 22(5):325-333. PubMed ID: 33247876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
    Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
    Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study.
    Aebi-Popp K; Kahlert CR; Crisinel PA; Decosterd L; Saldanha SA; Hoesli I; Martinez De Tejada B; Duppenthaler A; Rauch A; Marzolini C;
    J Antimicrob Chemother; 2022 Nov; 77(12):3436-3442. PubMed ID: 36177836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent data on the role of antiretroviral therapy in weight gain and obesity in persons living with HIV.
    Capeau J; Lagathu C; Béréziat V
    Curr Opin HIV AIDS; 2024 Jan; 19(1):14-20. PubMed ID: 38078606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.